CMG Pharmaceutical Co. Ltd (058820) — Cash Flow Quality Index
CMG Pharmaceutical Co. Ltd (058820) has a Cash Flow Quality Index of -0.71x as of September 2025. Operating cash flow of ₩-4.04 Billion is below net income of ₩5.73 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 058820 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CMG Pharmaceutical Co. Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CMG Pharmaceutical Co. Ltd (058820) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year earnings quality comparison for CMG Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see how much is CMG Pharmaceutical Co. Ltd worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩290.09 Million | ₩2.69 Billion | ▼ -82.2% |
| 2023 | 0.61x | ₩3.91 Billion | ₩6.46 Billion | ▼ -65.9% |
| 2021 | 1.78x | ₩5.63 Billion | ₩3.17 Billion | ▼ -87.0% |
| 2020 | 13.69x | ₩2.94 Billion | ₩215.00 Million | ▲ +1379.9% |
| 2019 | 0.93x | ₩2.82 Billion | ₩3.05 Billion | ▲ +532.9% |
| 2018 | 0.15x | ₩886.78 Million | ₩6.07 Billion | ▼ -78.7% |
| 2017 | 0.69x | ₩1.95 Billion | ₩2.83 Billion | ▼ -48.6% |
| 2016 | 1.34x | ₩2.31 Billion | ₩1.73 Billion | ▼ -70.9% |
| 2014 | 4.59x | ₩724.89 Million | ₩158.04 Million | — |